Targeting the untargetable
Panosome GmbH is a pioneering force in biotechnology research, dedicated to making previously inaccessible target classes, such as carbohydrates, peptides, and small molecules, addressable to antibodies. Originating from the German Cancer Research Center in 2020, Panosome GmbH leverages its revolutionary VAST technology to target antibodies across a spectrum of indications, from cancer to autoimmune diseases.
Located in Heidelberg, Badenwürttemberg 69123, DE, Panosome GmbH is committed to innovation and excellence in antibody development and gene delivery. The company's focus on anti-carbohydrate, anti-small molecule, and anti-peptide antibodies positions it as a leader in the next generation of therapeutic solutions.
Panosome GmbH continues to expand its capabilities and impact in the biotechnology sector. We invite the management team at Panosome GmbH to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform.
Other organizations in the same industry
This company is also known as